Invest now
Kwality Pharmaceuticals share price
High risk
You have to be logged in to add this to Watchlist.- ₹3,741.65(-0.25%)October 7, 2026 09:32:01 AM IST
- NSE
- BSE
- Vol : 1.01 K (NSE + BSE)Last 20 day avg : 56.65 K
Kwality Pharmaceuticals is trading -0.25% lower at Rs 3,741.65 as compared to its last closing price. Kwality Pharmaceuticals has been trading in the price range of 3,780.20 & 3,710.00. Kwality Pharmaceuticals has TTM P/E ratio 35.87 as compared to the sector P/E of 33.65.The company posted a net profit of 25.62 Crores in its last quarter.Listed peers of Kwality Pharmaceuticals include Sun Pharmaceutical Industries (-0.51%), Divi's Laboratories (-0.05%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in Kwality Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Kwality Pharmaceuticals was at 3.13% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 07 Oct 2026, 09:32 AM IST
- Debt To EquityHigher than industry0.39The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values11.40The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values46.65Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.91The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Kwality Pharmaceuticals Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,791.75 | -0.51 | 4,29,890.71 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,540.00 | -0.05 | 2,53,257.02 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,742.80 | -0.74 | 1,80,394.41 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,345.60 | 0.19 | 1,08,705.43 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,156.95 | -0.26 | 1,15,406.21 | 21.19 | 4.24 | 0.09 | 14.22 |
Kwality Pharmaceuticals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
About the company Kwality Pharmaceuticals
- IndustryBiotechnology & Drugs
- ISININE552U01010
- BSE Code539997
- NSE CodeKPL
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Kwality Pharmaceuticals Share Price FAQs
Kwality Pharmaceuticals is trading at 3741.65 as on Wed Oct 07 2026 04:02:01. This is -0.25% lower as compared to its previous closing price of 3641.50.
The market capitalization of Kwality Pharmaceuticals is 3882.41 Cr as on Wed Oct 07 2026 04:02:01.
The 52 wk high for Kwality Pharmaceuticals is 3866.55 whereas the 52 wk low is 828.80
Kwality Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 35.87
- Sector P/E: 33.65
- Dividend Yield: 0.00%
- D/E ratio: -
Kwality Pharmaceuticals reported a net profit of 67.35 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Kwality Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.